What amount sold does HealthScripts of America - Stafford, LLC report in Form D filings?

The latest linked filings report $50K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was HealthScripts of America - Stafford, LLC's most recent SEC filing?

HealthScripts of America - Stafford, LLC's most recent Form D filing was on 2014-02-18.

How many investors does HealthScripts of America - Stafford, LLC have?

The most recent Form D filing lists 6 investor(s).

What type of securities does HealthScripts of America - Stafford, LLC offer?

HealthScripts of America - Stafford, LLC's SEC Form D filings indicate equity offerings.

HealthScripts of America - Stafford, LLC

CIK: 0001600346·Pharmaceuticals·BELLAIRE, TX·Limited Liability Company·Founded 2013

Reported Sold

$50,000

Total Filings

Identified Offerings

Last Filed

Feb 18, 2014

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Feb 18, 2014Form D — New notice

Reported sold: $50,000 · Target: $200,000

Rule 506(b)·6 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$50,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Kamran Nezami

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 18, 2014	New	$200,000	$50,000	6

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

FibroBiologics, Inc.

Pharmaceuticals

Offering target: $1,200,000

Filed Oct 13, 2026